Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (31-40 of 367) with videos related to

Pageof 37
Sort By:
Hamostaseologie|April 27, 2025
Accelerated Fibrinolysis: A Tendency to Bleed?Dino Mehic, Ingrid Pabinger, Johanna Gebhart
Blood|August 3, 2013
Biomarkers for prediction of venous thromboembolism in cancerIngrid Pabinger, Johannes Thaler, Cihan Ay
Hamostaseologie|February 27, 2024
Bleeding Disorder of Unknown Cause: A Diagnosis of ExclusionDino Mehic, Johanna Gebhart, Ingrid Pabinger
European Heart Journal|August 14, 2024
From arteries to veins: the expanding role of lipid-lowering drugs in preventing thrombosisStephan Nopp, Cihan Ay, Ingrid Pabinger
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
<i>Research and Practice in Thrombosis and Haemostasis</i> - a new ISTH publishing platform for the global thrombosis and hemostasis communityIngrid Pabinger, Thomas Reiser, Jeffrey I Weitz
Haematologica|January 19, 2007
Rituximab for the treatment of acquired antibodies to factor VIIIWolfgang R Sperr, Klaus Lechner, Ingrid Pabinger
Thrombosis and Haemostasis|November 25, 2016
Cancer-associated venous thromboembolism: Burden, mechanisms, and managementCihan Ay, Ingrid Pabinger, Alexander T Cohen
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 12, 2021
Lower physical activity and altered body composition in patients with haemophilia compared with healthy controlsPeter Putz, Meike Klinger, Christoph Male, et al.
Biotechnology and Bioengineering|March 29, 2007
Peptides derived from a secretory yeast library restore factor VIII activity in the presence of an inhibitory antibodyChrista Mersich, Werner Billes, Ingrid Pabinger, et al.
Haematologica|February 6, 2014
Comment on Ferroni et al.: "Impact of chemotherapy on venous thromboembolism.: Comment to: Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study" HAEMATOL/2012/073338 and HAEMATOL/2013/092528Boris Dickmann, Jonas Ahlbrecht, Cihan Ay, et al.
Pageof 37

Showing results (31-40 of 367) with videos related to

Sort By:
Pageof 37
Hamostaseologie|April 27, 2025
Accelerated Fibrinolysis: A Tendency to Bleed?Dino Mehic, Ingrid Pabinger, Johanna Gebhart
Blood|August 3, 2013
Biomarkers for prediction of venous thromboembolism in cancerIngrid Pabinger, Johannes Thaler, Cihan Ay
Hamostaseologie|February 27, 2024
Bleeding Disorder of Unknown Cause: A Diagnosis of ExclusionDino Mehic, Johanna Gebhart, Ingrid Pabinger
European Heart Journal|August 14, 2024
From arteries to veins: the expanding role of lipid-lowering drugs in preventing thrombosisStephan Nopp, Cihan Ay, Ingrid Pabinger
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
<i>Research and Practice in Thrombosis and Haemostasis</i> - a new ISTH publishing platform for the global thrombosis and hemostasis communityIngrid Pabinger, Thomas Reiser, Jeffrey I Weitz
Haematologica|January 19, 2007
Rituximab for the treatment of acquired antibodies to factor VIIIWolfgang R Sperr, Klaus Lechner, Ingrid Pabinger
Thrombosis and Haemostasis|November 25, 2016
Cancer-associated venous thromboembolism: Burden, mechanisms, and managementCihan Ay, Ingrid Pabinger, Alexander T Cohen
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 12, 2021
Lower physical activity and altered body composition in patients with haemophilia compared with healthy controlsPeter Putz, Meike Klinger, Christoph Male, et al.
Biotechnology and Bioengineering|March 29, 2007
Peptides derived from a secretory yeast library restore factor VIII activity in the presence of an inhibitory antibodyChrista Mersich, Werner Billes, Ingrid Pabinger, et al.
Haematologica|February 6, 2014
Comment on Ferroni et al.: "Impact of chemotherapy on venous thromboembolism.: Comment to: Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study" HAEMATOL/2012/073338 and HAEMATOL/2013/092528Boris Dickmann, Jonas Ahlbrecht, Cihan Ay, et al.
Pageof 37